Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Healthcare & PharmaceuticalCompany Update

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

March 23, 2026 9:05 AM

Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent ("LOI") to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization. The proposed all stock transaction, if completed, is intended to enhance Wellgistics' existing revenue-generating healthcare platform by expanding capabilities adjacent to...

Read more
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies
Healthcare & PharmaceuticalCompany Update

MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies

March 23, 2026 9:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapies for neurologic, neuropsychiatric, and metabolic disorders, today announced new preclinical data demonstrating that Mira-55 did not produce cannabinoid-like central nervous system (CNS) side effects across a comprehensive battery of validated behavioral assays. The observed profile was differentiated from both...

Read more
Medical Component Specialists Expands Global Footprint with New State-of-the-Art Manufacturing Facility in Costa Rica
Healthcare & PharmaceuticalCompany Update

Medical Component Specialists Expands Global Footprint with New State-of-the-Art Manufacturing Facility in Costa Rica

March 23, 2026 9:00 AM

Medical Component Specialists (MCS) announced its expansion into Costa Rica's thriving medical device sector with the launch of a new state-of-the-art manufacturing facility, opening this summer. The move positions MCS within one of the world's fastest-growing medtech hubs and reinforces the company's commitment to delivering advanced manufacturing solutions to global partners. Following decades of sustained growth, medical devices became Costa...

Read more
Med-X to Showcase Nature-Cide at AMCA's 92nd Annual Meeting
Healthcare & PharmaceuticalConferences

Med-X to Showcase Nature-Cide at AMCA's 92nd Annual Meeting

March 23, 2026 8:31 AM

Med-X, Inc. ("Med-X" or the "Company") (Nasdaq:MXRX), a leading innovator in all-natural pest control solutions, today announced that its flagship Nature-Cide® product line will be featured at the American Mosquito Control Association's (AMCA) 92nd Annual Meeting, taking place March 23-27, 2026, at the Oregon Convention Center in Portland, Oregon. Attendees are invited to visit Nature-Cide at Booth 214 to explore the Company's full portfolio of...

Read more
Early Diagnosis and Local Solutions Are Critical To Combat Lung Cancer
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Early Diagnosis and Local Solutions Are Critical To Combat Lung Cancer

March 23, 2026 8:30 AM

Opinion: Despite advances in prevention and treatment, lung cancer remains the world's deadliest cancer largely because it is often detected too late. Strengthening local diagnostic capacity is one of the most effective ways to reduce the global burden of lung cancer. Originally published on Devex.com By Catharine Grimes, Raymond Osarogiagbon // 16 March 2026 Lung cancer remains the leading cause of cancer death worldwide. According to the World...

Read more
Restoring Strength and Energy: How Luna Acupuncture & Wellness Supports Chemotherapy Patients on the Road to Recovery
Healthcare & PharmaceuticalCompany Update

Restoring Strength and Energy: How Luna Acupuncture & Wellness Supports Chemotherapy Patients on the Road to Recovery

March 22, 2026 1:55 PM

For many cancer patients, chemotherapy represents both a life-saving treatment and a difficult physical journey. While chemotherapy plays a critical role in fighting cancer, the process often brings side effects that can linger long after treatment sessions end. Fatigue, nausea, pain, sleep disruption, and emotional stress frequently affect patients during and after chemotherapy. In Oregon, Luna Acupuncture & Wellness is helping patients manage...

Read more
Big Ed's Meds Erectile Dysfunction 2026: Sildenafil From $6, Tadalafil From $1.80 - Pricing, Process, and Key Details for First-Time Users
Healthcare & PharmaceuticalAdvertorial

Big Ed's Meds Erectile Dysfunction 2026: Sildenafil From $6, Tadalafil From $1.80 - Pricing, Process, and Key Details for First-Time Users

March 21, 2026 4:55 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Conditions discussed in this report should be evaluated by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any prescription treatment. This content may include referral links, and a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or...

Read more
Big Ed's Meds Premature Ejaculation Program in 2026: Sertraline Pricing, Telehealth Process, FDA and AUA/SMSNA Context, and What to Verify Before You Order
Healthcare & PharmaceuticalAdvertorial

Big Ed's Meds Premature Ejaculation Program in 2026: Sertraline Pricing, Telehealth Process, FDA and AUA/SMSNA Context, and What to Verify Before You Order

March 21, 2026 4:55 PM

Disclaimer: This is a paid advertorial. It is for informational purposes only and does not constitute medical advice. Premature ejaculation concerns should be evaluated by a qualified healthcare professional. Always consult a licensed clinician before starting any prescription treatment. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This does not change the...

Read more
Big Ed's Meds Hair Loss Treatment 2026: Finasteride Pricing, Telehealth Process, and What Men Should Know Before Ordering
Healthcare & PharmaceuticalAdvertorial

Big Ed's Meds Hair Loss Treatment 2026: Finasteride Pricing, Telehealth Process, and What Men Should Know Before Ordering

March 21, 2026 4:45 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Finasteride is a prescription medication that requires evaluation by a licensed healthcare provider. Always consult a qualified healthcare professional before starting any new prescription treatment. This content includes referral links. If a purchase is made through these links, a commission may be earned at no additional cost to you. This does...

Read more
Omax CryoFreeze Review 2026: Is Omax Health's Hemp Pain Relief Worth It?
Healthcare & PharmaceuticalAdvertorial

Omax CryoFreeze Review 2026: Is Omax Health's Hemp Pain Relief Worth It?

March 20, 2026 11:45 PM

Disclosure: This is a paid promotional advertorial. A commission may be earned if readers purchase through certain links in this article at no additional cost to the reader. This content summarizes publicly available product and brand information from Omax Health's official website and published sources. It is not independent editorial content, not independent medical advice, and should not be relied on as a substitute for professional medical...

Read more
Nutrivea Review 2026: Don't Buy Metabolic Support Formula Before Reading This Research First!
Healthcare & PharmaceuticalAdvertorial

Nutrivea Review 2026: Don't Buy Metabolic Support Formula Before Reading This Research First!

March 20, 2026 8:25 PM

Disclaimers: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the information presented. This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement, especially if you have existing health conditions, take...

Read more
PeterMD Enclomiphene Review 2026: Is the Oral TRT Option Worth It? Pricing, Labs, Process, and the Compliance Details to Know Before You Start
Healthcare & PharmaceuticalAdvertorial

PeterMD Enclomiphene Review 2026: Is the Oral TRT Option Worth It? Pricing, Labs, Process, and the Compliance Details to Know Before You Start

March 20, 2026 6:40 PM

Disclaimer: This article is for informational purposes only and is not medical advice. Prescription treatment decisions should be made with a licensed healthcare professional. This article may contain partner links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented. PeterMD Enclomiphene Complete 2026 Overview:...

Read more
Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET
Healthcare & PharmaceuticalConference Call

Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

March 20, 2026 3:35 PM

Tivic Health Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that it will report its year-end financial results for 2025 via pre-recorded conference call and webcast on Wednesday, March 25, 2026 at 1:30 PM PT / 4:30 PM ET. Conference Call and Webcast Information Teleconference Details: Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 910220 Webcast Link...

Read more
Not All CBD Is Medicine: Why Medicare's Plan Could Undermine FDA Marijuana Science
Healthcare & PharmaceuticalCompany Update

Not All CBD Is Medicine: Why Medicare's Plan Could Undermine FDA Marijuana Science

March 20, 2026 2:10 PM

In what may become one of the most controversial healthcare policy experiments in recent years, the Centers for Medicare & Medicaid Services (CMS) is preparing to launch a pilot program that would provide federal reimbursement for cannabidiol (CBD) products. On its surface, the initiative is framed as compassionate, forward-thinking, and responsive to patient demand - particularly among seniors suffering from chronic pain. But beneath the...

Read more
Avel eCare Calls for Virtual Health Integration in State Rural Health Transformation Strategies
Healthcare & PharmaceuticalCompany Update

Avel eCare Calls for Virtual Health Integration in State Rural Health Transformation Strategies

March 20, 2026 12:05 PM

States across the country are preparing to deploy $50 billion in federal funding through the Rural Health Transformation Program (RHT) to modernize care delivery, stabilize rural hospitals, and strengthen healthcare access for rural communities. The program, administered by CMS, is designed to help states advance five core priorities: Bring more care within reach Strengthen and sustain the rural clinical workforce Modernize rural health...

Read more
ASCP Supports Quality Measure Reform Following OIG Antipsychotic Use Reports
Healthcare & PharmaceuticalCompany Update

ASCP Supports Quality Measure Reform Following OIG Antipsychotic Use Reports

March 20, 2026 9:00 AM

The American Society of Consultant Pharmacists (ASCP) today issued the following statement regarding the two reports released by the Department of Health and Human Services Office of Inspector General (OIG) on March 19, 2026, concerning the use of antipsychotic drugs in nursing homes: "Nursing Homes' Inappropriate Use of Antipsychotic Drugs Poses a Risk to Residents" (OEI-02-23-00200) and the companion report on inappropriate schizophrenia...

Read more
TRNR Authorizes First Stock Repurchase Program; $500,000 Program Represents 20% Of Shares Outstanding at Last Closing Price
Healthcare & PharmaceuticalCompany Update

TRNR Authorizes First Stock Repurchase Program; $500,000 Program Represents 20% Of Shares Outstanding at Last Closing Price

March 20, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), owner and operator of the Wattbike, Ergatta, FORME and CLMBR fitness brands, today announced that its Board of Directors has authorized a stock repurchase program of up to $500,000 (the "Repurchase Program"). The Company intends to repurchase shares of its common stock on the open market through HC Wainwright & Co., LLC, subject to market conditions, applicable securities laws,...

Read more
Is SkinnyRx Legit? GLP-1 Platform Verification for 2026: Compounding Disclosures, FDA Context, Refund Terms, and a Step-by-Step Checklist for What to Verify Before You Enroll
Healthcare & PharmaceuticalAdvertorial

Is SkinnyRx Legit? GLP-1 Platform Verification for 2026: Compounding Disclosures, FDA Context, Refund Terms, and a Step-by-Step Checklist for What to Verify Before You Enroll

March 19, 2026 11:55 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Weight management concerns should be evaluated by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any prescription treatment. If you purchase through affiliate links in this article, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or...

Read more
Purisaki Deep Cleansing Foot Pads Review 2026: Don't Buy Before Reading This First!
Healthcare & PharmaceuticalAdvertorial

Purisaki Deep Cleansing Foot Pads Review 2026: Don't Buy Before Reading This First!

March 19, 2026 11:05 PM

Disclaimers: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. Statements about Purisaki have not been evaluated by the U.S. Food and Drug Administration. Purisaki is not intended to diagnose, treat, cure, or prevent any disease or condition. Readers with a medical condition, skin sensitivity, pregnancy, nursing status, or current medication use should consult a...

Read more
Sprout Health GLP-1 Review 2026: FDA Enforcement Context, Compounded Semaglutide and Tirzepatide Pricing, and a 10-Point Consumer Verification Checklist
Healthcare & PharmaceuticalAdvertorial

Sprout Health GLP-1 Review 2026: FDA Enforcement Context, Compounded Semaglutide and Tirzepatide Pricing, and a 10-Point Consumer Verification Checklist

March 19, 2026 8:55 PM

Disclaimer: This article is an informational advertorial reviewing publicly available disclosures from Sprout Health Partners LLC. It is not medical advice and does not constitute a professional recommendation. Weight management decisions should be made with a qualified healthcare professional. Compounded GLP-1 medications are prescription medications requiring evaluation by a licensed clinician. Prescription approval is not guaranteed. This...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?